TABLE 2.
RAS group (n = 15) | Control group (n = 15) | P-value | |
Age (years) | 66.67 ± 13.59 | 64.40 ± 13.41 | 0.821 |
Gender (male:female) | 13:2 | 10:5 | 0.195 |
Type (ischemic:hemorrhagic) | 10:5 | 12:3 | 0.409 |
Brunnstrom stage (IV:V:VI) | 9:4:2 | 10:3:2 | 0.907 |
Handedness (left:right) | 0:15 | 0:15 | 1.000 |
Damage hemisphere (left:right) | 7:8 | 8:7 | 0.833 |
Time (months) | 5.00 ± 7.55 | 3.77 ± 9.00 | 0.137 |
Intracranial lesion (number,%) | 0.707 | ||
Frontal temporal lobe | 1 (7%) | / | |
Frontal lobe | / | 1 (7%) | |
Corona radiate | 1 (7%) | / | |
Capsula externa | 1 (7%) | / | |
Thalamus | 2 (13%) | 1 (7%) | |
Basal ganglia | 9 (59%) | 8 (52%) | |
Brainstem | 1 (7%) | 3 (20%) | |
Paraventricular | / | 1 (7%) | |
Cerebellum | / | 1 (7%) |
RAS, rhythmic auditory stimulation.